|
WO2021063346A1
|
|
Kras g12c inhibitor and application thereof
|
|
WO2020108619A1
|
|
Mnk inhibitor
|
|
WO2020103897A1
|
|
Heterocyclic fused pyrimidine derivative, pharmaceutical composition thereof, and application thereof
|
|
WO2020057546A1
|
|
Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application
|
|
CN110467629A
|
|
Quinone derivatives, its pharmaceutical composition and application
|
|
CN110156656A
|
|
Five yuan of heteroaromatic ring derivatives, preparation method, pharmaceutical composition and application
|
|
CN110066236A
|
|
1H- azole derivatives, preparation method, pharmaceutical composition and application
|
|
CN109988204A
|
|
O- aryl glycoside derivative, its pharmaceutical composition and application
|
|
CN110066271A
|
|
Azole derivatives, preparation method, pharmaceutical composition and application
|
|
CN109956929A
|
|
Hete rocyclic derivatives, preparation method, pharmaceutical composition and application
|
|
WO2019120256A1
|
|
Five-membered heteroaryl ring derivative, pharmaceutical composition containing same, and application thereof
|
|
WO2019072143A1
|
|
4-aminopyridine derivative, pharmaceutical composition thereof, preparation method therefor and use thereof
|
|
WO2019037678A1
|
|
Pyrazolo[3,4-d]pyrimidin-3-one derivative, pharmaceutical composition and use thereof
|
|
WO2018192576A1
|
|
Method for preparing parp inhibitor compound, and intermediate, amorphous form, solvate, pharmaceutical composition, and application thereof
|
|
CN110386939A
|
|
The solvate crystals and preparation method thereof of PARP inhibitor
|
|
CN108727391A
|
|
PARP inhibitor compounds are amorphous and its preparation method and application
|
|
WO2018171633A1
|
|
Macrocyclic derivative of pyrazol[3,4-d]pyrimidin-3-one, pharmaceutical composition and use thereof
|
|
CN108148022A
|
|
Andrographolide class compound, its pharmaceutical composition and application
|
|
CN109721597A
|
|
Pyrido azepine derivate, its pharmaceutical composition and application
|
|
WO2018024188A1
|
|
Polycyclic compound, and manufacturing method, pharmaceutical composition, and application thereof
|
